Cephalon Overview

Founded 1987
Status Acquired/​Merged
Employees 800
Latest Deal Type M&A
Latest Deal Amount $6.8B
Latest Deal Amount

Cephalon General Information


Developer of pharmaceuticals intended to treat diseases related to central nervous system, oncology and inflammatory diseases. The company's pharmaceutical products are used for the treatment of sleep disorders, pain, addiction and cancer, enabling patients to find quick remedies for their diseases.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cephalon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Oct-2011 $6.8B 00.00 Completed Generating Revenue
3. Merger/Acquisition 05-Apr-2011 00.00 00.00 Cancelled Generating Revenue
2. IPO 25-Apr-1991 Completed Startup
1. Early Stage VC Completed Startup

Cephalon Former Investors (6)

To view Cephalon‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
New Leaf Venture Venture Capital Minority 000 0000 000000 0
New Science Ventures Venture Capital Minority 000 0000 000000 0
Oak Investment Partners Venture Capital Minority 000 0000 000000 0
SR One Corporate Venture Capital Minority 000 0000 000000 0

Cephalon Investments & Acquisitions (20)

To view Cephalon‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0ü0 000 10-Jan-2012 000000000000000000 Clinics/Outpatient Services
00000 0 0000000000 01-Apr-2011 000000000000000000 00000 Pharmaceuticals
000000000 00000000 29-Mar-2011 000000000000000000 00000 Biotechnology
000000000 11-Feb-2011 0000 00000 Biotechnology
Alba Therapeutics (Larazotide Acetate Assets) 09-Feb-2011 Corporate Asset Purchase 0000 Biotechnology 00000 00000

Ready to get started?

Request a free trial

Cephalon Subsidiaries (2)

Company Name Industry Location Founded
Fachklinik für Amputationsmedizin Osterhofen Clinics/Outpatient Services Osterhofen, Germany 1999
00000 Biotechnology Basel, Switzerland 0000

Cephalon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 05-Jan-2004 00000 00000 00 00.000 Completed
  • 5 buyers